BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12390315)

  • 1. Risk factors in HIV-1-infected patients developing repetitive bacterial infections: toxicological, clinical, specific antibody class responses, opsonophagocytosis and Fc(gamma) RIIa polymorphism characteristics.
    Payeras A; Martinez P; Milà J; Riera M; Pareja A; Casal J; Matamoros N
    Clin Exp Immunol; 2002 Nov; 130(2):271-8. PubMed ID: 12390315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections.
    Sanders LA; van de Winkel JG; Rijkers GT; Voorhorst-Ogink MM; de Haas M; Capel PJ; Zegers BJ
    J Infect Dis; 1994 Oct; 170(4):854-61. PubMed ID: 7930727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.
    Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T
    Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults.
    Chen M; Ssali F; Mulungi M; Awio P; Yoshimine H; Kuroki R; Furumoto A; Tanimura S; Kityo C; Nagatake T; Mugyenyi P; Oishi K
    Vaccine; 2008 Sep; 26(38):4962-8. PubMed ID: 18639599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological effect of vaccination against pneumococcal infection in HIV-infected children].
    Pakhomov DV; Kostinov MP; Poddubikov AV; Vaneeva NP; Snegova NF; Nikitina TN; Zinkina TN; Suloeva SV
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):48-52. PubMed ID: 19459477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
    D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
    AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Immunization of HIV-Infected Adults in the UK With Haemophilus influenzae b/Meningococcal C Glycoconjugate and Pneumococcal Polysaccharide Vaccines.
    MacLennan CA; Richter A; Hodson J; Faustini S; Birtwistle J; Whitelegg A; Chigiga J; Singo M; Walker-Haywood J; Mulugeta B; Masuka S; Mainey C; Plant T; Drayson MT; Manavi K
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):287-293. PubMed ID: 27163175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of (partial) immune defects and risk of recurrent respiratory infections.
    Bossuyt X; Moens L; Van Hoeyveld E; Jeurissen A; Bogaert G; Sauer K; Proesmans M; Raes M; De Boeck K
    Clin Chem; 2007 Jan; 53(1):124-30. PubMed ID: 17110469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients.
    Mayaud C; Parrot A; Cadranel J
    Eur Respir J Suppl; 2002 Jul; 36():28s-39s. PubMed ID: 12168745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.
    Sanders LA; Feldman RG; Voorhorst-Ogink MM; de Haas M; Rijkers GT; Capel PJ; Zegers BJ; van de Winkel JG
    Infect Immun; 1995 Jan; 63(1):73-81. PubMed ID: 7806386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study.
    Falcó V; Jordano Q; Cruz MJ; Len O; Ribera E; Campins M; Crespo M; Ocaña I; Rodrigo MJ; Pahissa A
    Vaccine; 2006 Mar; 24(14):2567-74. PubMed ID: 16423429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
    Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
    Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine.
    Weiss PJ; Wallace MR; Oldfield EC; O'Brien J; Janoff EN
    J Infect Dis; 1995 May; 171(5):1217-22. PubMed ID: 7751696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of Fc receptor IIa for immunoglobulin G is associated with placental malaria in HIV-1-positive women in western Kenya.
    Brouwer KC; Lal AA; Mirel LB; Otieno J; Ayisi J; Van Eijk AM; Lal RB; Steketee R; Nahlen BL; Shi YP
    J Infect Dis; 2004 Sep; 190(6):1192-8. PubMed ID: 15319871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy.
    Subramaniam KS; Segal R; Lyles RH; Rodriguez-Barradas MC; Pirofski LA
    J Infect Dis; 2003 Mar; 187(5):758-68. PubMed ID: 12599049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.
    Hung CC; Chang SY; Su CT; Chen YY; Chang SF; Yang CY; Liu WC; Wu CH; Chang SC
    HIV Med; 2010 Jan; 11(1):54-63. PubMed ID: 19659943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing bacterial respiratory tract infections among persons infected with human immunodeficiency virus.
    Keller DW; Breiman RF
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S77-83. PubMed ID: 8547517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The controversial impact of B cells subsets on immune response to pneumococcal vaccine in HIV-1 patients.
    Tsachouridou O; Skoura L; Zebekakis P; Margariti A; Georgiou A; Daniilidis M; Malisiovas N; Metallidis S
    Int J Infect Dis; 2015 Sep; 38():24-31. PubMed ID: 26192868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc gamma receptor allotypes in children with bacterial meningitis. A preliminary study.
    Tezcan I; Berkel AI; Ersoy F; Sanal O; Kanra G
    Turk J Pediatr; 1998; 40(4):533-8. PubMed ID: 10028861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
    Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.